Upgrades
- For AnaptysBio Inc ANAB, Guggenheim upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, AnaptysBio showed an EPS of $0.79, compared to $0.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of 39.48 and a 52-week-low of 10.0. AnaptysBio closed at $17.76 at the end of the last trading period.
- According to Loop Capital, the prior rating for American Eagle Outfitters Inc AEO was changed from Sell to Hold. In the second quarter, American Eagle Outfitters showed an EPS of $0.03, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of 16.825 and a 52-week-low of 6.535. American Eagle Outfitters closed at $14.80 at the end of the last trading period.
- According to UBS, the prior rating for Workday Inc WDAY was changed from Sell to Neutral. In the second quarter, Workday showed an EPS of $0.84, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of 248.75 and a 52-week-low of 107.75. At the end of the last trading period, Workday closed at $232.90.
- For AutoZone Inc AZO, Raymond James upgraded the previous rating of Outperform to the current rating Strong Buy. AutoZone earned $30.93 in the fourth quarter, compared to $20.95 in the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of 1274.4075 and a 52-week-low of 684.91. Moreover, at the end of the last trading period, the closing price was at $1165.71.
- JP Morgan upgraded the previous rating for NIO Inc NIO from Neutral to Overweight. NIO earned $0.15 in the second quarter, compared to $0.45 in the year-ago quarter. The current stock performance of NIO shows a 52-week-high of 22.59 and a 52-week-low of 1.36. Moreover, at the end of the last trading period, the closing price was at $21.61.
- According to Jefferies, the prior rating for Beacon Roofing Supply Inc BECN was changed from Hold to Buy. For the third quarter, Beacon Roofing Supply had an EPS of $1.01, compared to year-ago quarter EPS of $0.32. The stock has a 52-week-high of 37.06 and a 52-week-low of 11.665. At the end of the last trading period, Beacon Roofing Supply closed at $35.43.
- For Theravance Biopharma Inc TBPH, Morgan Stanley upgraded the previous rating of Equal-Weight to the current rating Overweight. Theravance Biopharma earned $1.00 in the second quarter, compared to $0.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of 31.54 and a 52-week-low of 14.48. Theravance Biopharma closed at $17.28 at the end of the last trading period.
Downgrades
- B of A Securities downgraded the previous rating for Paramount Group Inc PGRE from Neutral to Underperform. In the second quarter, Paramount Group showed an EPS of $0.23, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of 15.0 and a 52-week-low of 6.42. Paramount Group closed at $7.00 at the end of the last trading period.
- According to UBS, the prior rating for Splunk Inc SPLK was changed from Buy to Sell. For the second quarter, Splunk had an EPS of $0.33, compared to year-ago quarter EPS of $0.67. At the moment, the stock has a 52-week-high of 225.8944 and a 52-week-low of 93.92. Splunk closed at $215.83 at the end of the last trading period.
- For Constellation Brands Inc STZ, Atlantic Equities downgraded the previous rating of Overweight to the current rating Neutral. For the second quarter, Constellation Brands had an EPS of $2.76, compared to year-ago quarter EPS of $2.72. At the moment, the stock has a 52-week-high of 208.55 and a 52-week-low of 104.28. Constellation Brands closed at $187.57 at the end of the last trading period.
- According to JP Morgan, the prior rating for Invitae Corp NVTA was changed from Overweight to Neutral. For the second quarter, Invitae had an EPS of $0.77, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of 55.38 and a 52-week-low of 7.415. At the end of the last trading period, Invitae closed at $52.59.
- For Livongo Health Inc LVGO, JP Morgan downgraded the previous rating of Overweight to the current rating Neutral. In the second quarter, Livongo Health showed an EPS of $0.11, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of 151.049 and a 52-week-low of 17.25. At the end of the last trading period, Livongo Health closed at $148.08.
- For Albemarle Corp ALB, RBC Capital downgraded the previous rating of Sector Perform to the current rating Underperform. For the second quarter, Albemarle had an EPS of $0.86, compared to year-ago quarter EPS of $1.55. At the moment, the stock has a 52-week-high of 101.0 and a 52-week-low of 48.8901. Albemarle closed at $95.10 at the end of the last trading period.
- KeyBanc downgraded the previous rating for Pentair PLC PNR from Overweight to Sector Weight. For the second quarter, Pentair had an EPS of $0.59, compared to year-ago quarter EPS of $0.69. At the moment, the stock has a 52-week-high of 50.52 and a 52-week-low of 22.01. Pentair closed at $49.28 at the end of the last trading period.
Initiations
- With a current rating of Equal-Weight, Stephens & Co. initiated coverage on West Pharmaceutical Services Inc WST. The price target seems to have been set at $300.00 for West Pharmaceutical Servs. For the second quarter, West Pharmaceutical Servs had an EPS of $1.25, compared to year-ago quarter EPS of $0.89. The current stock performance of West Pharmaceutical Servs shows a 52-week-high of 303.14 and a 52-week-low of 124.53. Moreover, at the end of the last trading period, the closing price was at $299.45.
- With a current rating of Buy, Citigroup initiated coverage on PNM Resources Inc PNM. The price target seems to have been set at $51.00 for PNM Resources. In the second quarter, PNM Resources showed an EPS of $0.55, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of 56.14 and a 52-week-low of 27.08. PNM Resources closed at $45.50 at the end of the last trading period.
- With a current rating of Buy, Deutsche Bank initiated coverage on 1Life Healthcare Inc ONEM. The price target seems to have been set at $37.00 for 1Life Healthcare. 1Life Healthcare earned $0.24 in the second quarter. The current stock performance of 1Life Healthcare shows a 52-week-high of 44.87 and a 52-week-low of 15.0. Moreover, at the end of the last trading period, the closing price was at $29.70.
- UBS initiated coverage on VMware Inc VMW with a Neutral rating. The price target for VMware is set to $155.00. VMware earned $1.81 in the second quarter, compared to $1.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of 173.37 and a 52-week-low of 86.0. VMware closed at $155.04 at the end of the last trading period.
- UBS initiated coverage on Veeva Systems Inc VEEV with a Sell rating. The price target for Veeva Systems is set to $225.00. For the second quarter, Veeva Systems had an EPS of $0.72, compared to year-ago quarter EPS of $0.55. At the moment, the stock has a 52-week-high of 312.0 and a 52-week-low of 118.11. Veeva Systems closed at $308.84 at the end of the last trading period.
- UBS initiated coverage on Oracle Corp ORCL with a Neutral rating. The price target for Oracle is set to $62.00. For the first quarter, Oracle had an EPS of $0.93, compared to year-ago quarter EPS of $0.81. At the moment, the stock has a 52-week-high of 62.5999 and a 52-week-low of 39.71. Oracle closed at $60.97 at the end of the last trading period.
- Morgan Stanley initiated coverage on New York Times Co NYT with an Overweight rating. The price target for New York Times is set to $55.00. In the second quarter, New York Times showed an EPS of $0.18, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of 47.95 and a 52-week-low of 26.13. New York Times closed at $43.41 at the end of the last trading period.
- For Intellia Therapeutics Inc NTLA, Wells Fargo initiated coverage, by setting the current rating at Overweight. Intellia Therapeutics earned $0.61 in the second quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of 26.77 and a 52-week-low of 9.18. Intellia Therapeutics closed at $24.61 at the end of the last trading period.
- UBS initiated coverage on ServiceNow Inc NOW with a Buy rating. The price target for ServiceNow is set to $600.00. In the second quarter, ServiceNow showed an EPS of $1.23, compared to $0.71 from the year-ago quarter. The stock has a 52-week-high of 522.77 and a 52-week-low of 213.99. At the end of the last trading period, ServiceNow closed at $518.22.
- HC Wainwright & Co. initiated coverage on Compass Pathways PLC CMPS with a Buy rating. The price target for Compass Pathways is set to $65.00. The current stock performance of Compass Pathways shows a 52-week-high of 47.29 and a 52-week-low of 22.51. Moreover, at the end of the last trading period, the closing price was at $38.82.
- With a current rating of Outperform, CICC initiated coverage on Niu Technologies NIU. The price target seems to have been set at $31.00 for Niu Technologies. In the second quarter, Niu Technologies showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of 28.4899 and a 52-week-low of 6.08. At the end of the last trading period, Niu Technologies closed at $27.37.
- UBS initiated coverage on Microsoft Corp MSFT with a Buy rating. The price target for Microsoft is set to $243.00. For the fourth quarter, Microsoft had an EPS of $1.46, compared to year-ago quarter EPS of $1.37. At the moment, the stock has a 52-week-high of 232.86 and a 52-week-low of 132.52. Microsoft closed at $222.86 at the end of the last trading period.
- UBS initiated coverage on DocuSign Inc DOCU with a Buy rating. The price target for DocuSign is set to $290.00. For the second quarter, DocuSign had an EPS of $0.17, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of 290.23 and a 52-week-low of 61.68. At the end of the last trading period, DocuSign closed at $238.21.
- UBS initiated coverage on Citrix Systems Inc CTXS with a Neutral rating. The price target for Citrix Systems is set to $146.00. For the second quarter, Citrix Systems had an EPS of $1.53, compared to year-ago quarter EPS of $1.21. At the moment, the stock has a 52-week-high of 173.56 and a 52-week-low of 97.45. Citrix Systems closed at $144.03 at the end of the last trading period.
- UBS initiated coverage on Salesforce.com Inc CRM with a Buy rating. The price target for Salesforce.com is set to $325.00. For the second quarter, Salesforce.com had an EPS of $1.44, compared to year-ago quarter EPS of $0.66. At the moment, the stock has a 52-week-high of 284.5 and a 52-week-low of 115.29. Salesforce.com closed at $266.76 at the end of the last trading period.
- With a current rating of Buy, HC Wainwright & Co. initiated coverage on Humanigen Inc HGEN. The price target seems to have been set at $31.00 for Humanigen. Humanigen earned $0.16 in the second quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of 33.95 and a 52-week-low of 3.4. Humanigen closed at $12.03 at the end of the last trading period.
- With a current rating of Buy, Needham initiated coverage on Calix Inc CALX. The price target seems to have been set at $25.00 for Calix. Calix earned $0.14 in the second quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of 22.69 and a 52-week-low of 5.61. At the end of the last trading period, Calix closed at $19.50.
- Wedbush initiated coverage on Unity Software Inc U with an Outperform rating. The price target for Unity Software is set to $125.00. The current stock performance of Unity Software shows a 52-week-high of 102.63 and a 52-week-low of 65.11. Moreover, at the end of the last trading period, the closing price was at $92.19.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in